- Home
- OWLS vs ABSI Comparison
OWLS vs ABSI Comparison
Compare OWLS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OWLS | ABSI |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.3M | 577.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OWLS | ABSI |
|---|---|---|
| Price | $6.21 | $3.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 67.9K | ★ 3.9M |
| Earning Date | 12-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,569,630.00 | $2,815,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $437.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.29 | N/A |
| 52 Week Low | $6.03 | $2.01 |
| 52 Week High | $90.00 | $6.33 |
Technical Indicators
Market Signals| Indicator | OWLS | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.17 |
| Support Level | N/A | $3.37 |
| Resistance Level | N/A | $3.79 |
| Average True Range (ATR) | 0.00 | 0.25 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 34.51 |
Price Performance
Historical ComparisonAbout OWLS OBOOK Holdings Inc.
OBOOK Holdings Inc is focused on using blockchain technology to provide inventive solutions to customers in various sectors, including financial services, hospitality, and e-commerce. Through its e-commerce, hospitality and payments offerings, it is committed to serving businesses and individuals whose commercial activities involve cross-border transactions.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.